Skip to main content
Meyer Lifschitz, MD, Nephrology, FPO, AP

MeyerDLifschitzMD

Nephrology FPO, AP

Acute Renal Failure, Hypertension, Renovascular Medicine

Staff Nephrologist, Jerusalem, Israel

Dr. Lifschitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Lifschitz's full profile

Already have an account?

  • Office

    Shaare Zedek Medical Center
    Jerusalem, Israel
    FPO, AP 96427

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1971 - 1973
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterInternship, Internal Medicine, 1970 - 1971
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemInternship, Internal Medicine, 1967 - 1968
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1967
  • Boston University
    Boston UniversityMA, Physiology, 1966
  • Massachusetts Institute of Technology
    Massachusetts Institute of TechnologyBS, 1963

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2004 - 2028
  • DC State Medical License
    DC State Medical License 2007 - 2013

Awards, Honors, & Recognition

  • Alpha Omega Alpha Begg Society, 1966
  • Whos Who in Medicine and Healthcare Marquis Whos Who

Publications & Presentations

PubMed

Journal Articles

  • Preoperative Renal Dysfunction and Anemia Predict outcomes after cardiac surgery  
    Linda Shavit, Meyer Lifschitz, Rachel Tauber, Daniel Bitran and Daniel Fink, CJASN, 7/1/2014
  • Long-term Hypoparathyroidism and Hypophosphatemia in a Dialysis Patient  
    L Shavit, M Lifschitz and I Slotki, Journal of Investigative Medicine High Impact Case Reports, 5/1/2014
  • Pegylated liposomal do:xorubicin and renal thrombotic microangiopathy: an under recognized complication of prolonged treatment  
    L Shavit, M Lifschitz et al, Kidney Inter, 1/1/2014
  • Join now to see all